Welcome to our dedicated page for Evolv Technologies Hldngs SEC filings (Ticker: EVLV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The EVLV SEC filings page on Stock Titan aggregates regulatory documents for Evolv Technologies Holdings, Inc., whose Class A common stock and warrants trade on The Nasdaq Stock Market under the symbols EVLV and EVLVW. These filings provide structured insight into how the company reports its financial performance, capital structure, governance decisions, and key agreements related to its AI-powered security screening business.
Among the most closely watched documents for Evolv are its annual reports on Form 10-K and quarterly reports on Form 10-Q, which detail revenue composition between recurring subscription and non-recurring product and services, discuss metrics such as Annual Recurring Revenue, and describe risks and operational considerations connected to its security technology offerings. Current reports on Form 8-K disclose specific material events, including the announcement of quarterly financial results, entry into credit agreements, changes in executive roles, and outcomes of shareholder votes at the annual meeting.
Filings also describe Evolv’s capital and financing arrangements, such as senior secured credit facilities documented in a Credit, Security and Guaranty Agreement, and registration statements or post-effective amendments that address the registration of securities and warrant exercises. Proxy materials and related disclosures explain matters submitted to stockholders, including director elections, advisory votes on executive compensation, and auditor ratification.
On Stock Titan, EVLV filings are updated as new documents are posted to the SEC’s EDGAR system. AI-powered summaries help explain lengthy filings by highlighting key points, such as changes in liquidity, covenant requirements, revenue mix, or governance decisions, without replacing the underlying source documents. Users can also review Section 16 and Form 4 filings to monitor insider transactions and equity awards, adding another dimension to their analysis of Evolv’s governance and incentive structures.
Together, these filings form a detailed record of how Evolv communicates with regulators and investors about its financial condition, risk factors, and significant corporate events related to its AI-based security technology business.
Evolv Technologies (NASDAQ:EVLV) filed a routine Form 4 disclosing an equity award to director Neil Glat. On June 20, 2025, Glat received 27,050 Restricted Stock Units (RSUs), each representing one share of Class A common stock. The RSUs carry no exercise price and will vest in full on the earlier of June 20, 2026 or the day immediately preceding the company’s next annual meeting. Following the grant, Glat beneficially owns 27,050 shares directly. No sales, dispositions, or other material transactions were reported.
Director Mark J. Sullivan of Evolv Technologies Holdings (EVLV) received a grant of 27,050 Restricted Stock Units (RSUs) on June 20, 2025. Each RSU represents the right to receive one share of Class A common stock.
Key terms of the RSU grant:
- The RSUs will fully vest on the earlier of June 20, 2026 or the day before the next annual meeting
- The RSUs were granted at no cost ($0)
- The securities are held in direct ownership
- The RSUs have no expiration date
This Form 4 filing was submitted by Rachel Roy as attorney-in-fact for Mark Sullivan on June 24, 2025, within the required reporting window for insider transactions.
Evolv Technologies Holdings, Inc. (EVLV) – Form 4 Insider Transaction
Director Bilal Zuberi reported the receipt of 27,050 Restricted Stock Units (RSUs) on 20 June 2025. Each RSU converts into one share of EVLV Class A common stock upon vesting. The award will vest in full on the earlier of 20 June 2026 or the day immediately preceding the company’s next annual shareholder meeting. No cash was paid for the RSUs (exercise price = $0), and there is no expiration date.
Following the grant, Zuberi beneficially owns 27,050 derivative securities; no additional non-derivative share holdings were disclosed in this filing. The filing reflects standard equity compensation for board members and does not indicate any share sales or purchases in the open market.
Given EVLV’s public float, the share count involved is immaterial from a dilution standpoint, but the award reinforces director/shareholder alignment without immediate cash outflow by the company.
Evolv Technologies Holdings (EVLV) reported a Form 4 filing disclosing an insider transaction by Director David Mounts Gonzales on June 20, 2025. The director was granted 27,050 Restricted Stock Units (RSUs) as part of the company's equity compensation plan.
Key details of the RSU grant:
- Each RSU represents a right to receive one share of Class A common stock
- The RSUs were granted at $0 cost to the director
- Vesting will occur in full at the earlier of June 20, 2026 or the day before the next annual meeting
- The RSUs have no expiration date
This transaction appears to be part of standard director compensation arrangements. The filing was signed by Rachel Roy as attorney-in-fact for David Mounts Gonzales on June 24, 2025.